Category Genetics
Press Release
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy. Read More
Press Release
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More
Press Release
Genome Editing Market Revenue to Cross USD 10 Bn by 2026: Global Market Insights, Inc.
Asia Pacific genome editing market will showcase growth of 15% during the forecast period owing to increasing number of genetic research organizations in emerging economies that are working on the development of innovative gene-editing tools. Read More
Press Release
BillionToOne, Inc. and Eluthia Launch UNITY™ Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands
BillionToOne and Eluthia have announced today the launch of the first and only non-invasive prenatal test, allowing to screen for the autosomal-recessive conditions cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease and other hemoglobinopathies. The UNITY™ screen will be made available through Eluthia in Germany, Austria, Switzerland, and the Netherlands, as of now. Read More
Press Release
Landmark Study Seeks Participants With VCFS-Related Psychosis to Help Create Biobank of Human Neural Tissue to Develop Innovative Treatments
The Virtual Center for Velo-Cardio-Facial Syndrome collaborates with the Center for Precision Neuropsychiatry based in the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons Read More
Press Release
Dante Labs Launches GenomeL, the First Commercial Long Reads Human Whole Genome Sequencing
Dante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy. Read More
Press Release
Color Partners With Sayre Therapeutics to Provide Access to Affordable Hereditary Cancer Assessment Tests in India
The Color-Sayre partnership will provide a fully integrated solution for patients and providers by delivering actionable clinical test results at an accessible price point. Read More
Press Release
Rainbow Genomics and Color Genomics Team Up to Provide Access to Affordable Hereditary Cancer and Heart Health Genetic Risk Assessment Tests in Asia
Partnership combines local support with global capabilities to deliver affordable tests to identify genetic mutations associated with an increased risk for hereditary cancer and inherited heart conditions for which early knowledge can make a difference. Read More
Press Release
An NGS Approach for Research on the Genetic Determinants of Female and Male Infertility, New Webinar Hosted by Xtalks
Comprehensive Interrogation of the Genetic Determinants of Female and Male Infertility: A New NGS Research Application Enabled by Improvements in Target Enrichment Technology Read More
Press Release
Ehlers-Danlos Society Receives Transformational Gift for Genomic Research Into Rare Disorder, HyperMobile EDS
Anonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder Read More
Press Release
Rombergers Marking 263 Years in the U.S.
On June 18th, Berrysburg's historic Hill Church provides a bucolic backdrop to the Romberger All-Family Reunion where friends, food, fun and genealogy rule. Descendants of Bartel, the original immigrant ancestor for American Rombergers (and variations) meet once more to share info, make new family friends, and celebrate the life of the family association founder, Dr. John Romberger. Read More
Press Release
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. Read More
Press Release
Monitoring Endangered Species With DNA (Like Jurassic Park)
A new way to monitor & protect endangered species. Using DNA analysis of animal blood from creatures that feed on animals. Scientists can now map animal populations at the highest resolution ever. Also, this method will scale globally. Read More
Press Release